Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic AMP, the hyperresponsiveness factor from hog kidney.

H T Miller, W Yesus, L Golden

    Life Sciences
    |October 13, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

    Physical review letters·2026
    Same author

    Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

    Physical review letters·2026
    Same author

    Observation of tWZ Production at the CMS Experiment.

    Physical review letters·2026
    Same author

    First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

    Physical review letters·2026
    Same journal

    MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

    Life sciences·2026
    Same journal

    TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

    Life sciences·2026
    Same journal

    Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

    Life sciences·2026
    Same journal

    Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

    Life sciences·2026
    Same journal

    METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

    Life sciences·2026
    Same journal

    SLC30A9-mediated mitochondrial zinc homeostasis drives osteosarcoma chemoresistance by suppressing the mtDNA-cGAS-STING pathway.

    Life sciences·2026
    See all related articles

    Researchers identified that a substance from hog kidneys, which causes increased blood pressure responses to norepinephrine, is actually the molecule cyclic AMP. This discovery helps explain how certain renal factors contribute to hypertensive states in both animals and humans.

    Area of Science:

    • Renal physiology and Cyclic AMP signaling pathways
    • Cardiovascular medicine and hypertension research

    Background:

    No prior work had resolved the exact chemical identity of the substance responsible for heightened vascular sensitivity in hypertensive subjects. Researchers observed that plasma from hypertensive dogs triggered an exaggerated reaction to norepinephrine administration. This phenomenon suggested the presence of a specific circulating factor influencing blood pressure regulation. Early investigations focused on isolating this material from various biological sources to characterize its properties. That uncertainty drove scientists to examine renal tissues as a potential origin for the observed physiological effects. Previous studies established that intravenous delivery of these fractions consistently altered arterial pressure responses in animal models. The scientific community lacked a definitive molecular classification for this renal-derived agent for several decades. This gap motivated a rigorous analytical comparison between the unknown factor and known signaling molecules.

    Purpose Of The Study:

    The study aimed to isolate and identify the specific material responsible for hyperresponsiveness in hypertensive subjects. Researchers sought to determine the chemical nature of a factor previously detected in the plasma of hypertensive dogs and humans. This work addressed the long-standing uncertainty regarding the origin of substances that amplify vascular reactions to norepinephrine. The team focused on hog kidney as a potential source for this active biological agent. By isolating fractions from renal tissue, they intended to characterize the molecule through various analytical techniques. The motivation stemmed from the need to understand how renal-derived factors influence systemic blood pressure regulation. Establishing the identity of this material was essential for advancing knowledge of hypertensive pathophysiology. This investigation sought to provide a definitive classification for the factor that causes exaggerated responses to vasopressor agents.

    Keywords:
    norepinephrine sensitivityrenal physiologyvasoconstriction mechanismsblood pressure regulation

    Frequently Asked Questions

    The researchers propose that cyclic AMP acts as the active agent causing increased sensitivity to norepinephrine. This mechanism was confirmed by comparing the isolated renal fraction to known cyclic AMP across multiple analytical tests, including molecular weight and ultraviolet spectrum analysis.

    The team utilized a rat assay system involving anesthetized subjects. They inserted polyethylene catheters into the vein for administering norepinephrine and test fractions, while using an arterial catheter to monitor real-time blood pressure changes.

    Anesthetized rats were necessary to maintain stable physiological conditions for monitoring blood pressure. This setup allowed researchers to isolate the specific effects of the test fractions on arterial pressure without interference from conscious movement or stress-induced hormonal fluctuations.

    Related Experiment Videos

    Main Methods:

    The investigation utilized a rat assay system to evaluate the biological activity of various renal-derived fractions. Scientists anesthetized the animals to ensure controlled conditions during the administration of test materials. Polyethylene tubing served as the primary conduit for delivering norepinephrine and the isolated hog kidney extracts into the venous circulation. Investigators monitored arterial pressure continuously to detect any deviations in vascular response. They performed comparative analyses using ultraviolet spectroscopy to determine the structural characteristics of the unknown substance. Paper chromatography provided a secondary method for verifying the chemical composition of the active material. The team applied enzyme hydrolysis to observe how the factor degraded compared to known standards. This comprehensive approach allowed for the precise identification of the renal-derived agent.

    Main Results:

    The strongest finding indicates that the renal-derived hyperresponsiveness factor is identical to cyclic AMP. Analytical comparisons showed that the isolated material matches the molecular weight of the known nucleotide. Ultraviolet spectrum data confirmed the structural similarity between the two substances. The researchers observed consistent results across paper chromatography tests for both the renal fraction and the standard. Enzyme hydrolysis confirmed that the biological activity of the kidney extract behaves exactly like cyclic AMP. The rat assay system demonstrated that the isolated material induces a heightened response to norepinephrine. This effect was observed consistently when both substances were administered intravenously. The data collectively support the conclusion that the renal factor is indeed cyclic AMP.

    Conclusions:

    The authors conclude that the renal-derived substance is chemically indistinguishable from cyclic AMP. This identification relies on matching molecular weight and ultraviolet absorption profiles between the two materials. Paper chromatography results further support the equivalence of the isolated factor and the known nucleotide. Enzyme hydrolysis experiments demonstrate that both substances respond identically to degradative processes. The researchers propose that this molecule acts as a mediator for the observed hyperresponsiveness to norepinephrine. These findings suggest that cyclic AMP plays a role in the physiological regulation of blood pressure. The study provides a clear link between renal output and systemic vascular sensitivity. Future investigations might explore how this pathway contributes to clinical hypertension in human patients.

    The researchers used test fractions derived from hog kidney to identify the active material. These fractions were compared against standard cyclic AMP using paper chromatography and enzyme hydrolysis to verify their chemical identity.

    The study measured the hyperresponsiveness to norepinephrine, defined as an exaggerated blood pressure increase. This phenomenon was compared between subjects receiving only the hormone and those receiving the hormone alongside the isolated renal material.

    The authors propose that their findings clarify the origin of the hyperresponsiveness factor. They suggest that cyclic AMP, originating from the kidneys, is the specific molecule responsible for the heightened vascular sensitivity observed in hypertensive subjects.